Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs
Mohsen Hosseini(Princess Margaret Cancer Centre), Véronique Voisin(Occupational Cancer Research Centre), Ali Chegini(University of Toronto), Angelica Varesi(University of Toronto), Séverine Cathelin(Princess Margaret Cancer Centre), Dhanoop Manikoth Ayyathan(Princess Margaret Cancer Centre), Alex C.H. Liu(University of Toronto), Yitong Yang(University of Toronto), Vivian Wang(University of Toronto), Abdula Maher(Princess Margaret Cancer Centre), Éric Grignano(Princess Margaret Cancer Centre), Julie A. Reisz(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Kira Young(Jackson Laboratory), Yiyan Wu(University of Toronto), Martina Fiumara(Vita-Salute San Raffaele University), Samuele Ferrari(Vita-Salute San Raffaele University), Luigi Naldini(Vita-Salute San Raffaele University), Federico Gaiti(University of Toronto), Shraddha Pai(Ontario Institute for Cancer Research), Grace Egan(Hospital for Sick Children), Aaron D. Schimmer(University of Toronto), Gary D. Bader(Occupational Cancer Research Centre), John E. Dick(University of Toronto), Stephanie Z. Xie(Princess Margaret Cancer Centre), Jennifer J. Trowbridge(Jackson Laboratory), Steven M. Chan(University of Toronto)
Cited by 42
Abstract
Related Papers
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick et al.|New England Journal of Medicine|2014|4.7k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese, Anna K. Kähler, Robert E. Handsaker et al.|New England Journal of Medicine|2014|3.5k
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J. Silver et al.|New England Journal of Medicine|2017|2.6k